4.6 Schleicher, GammaMed and MammoSite - Varian

More documents

Recommendations

Info

100 80 60 40 20 0 10 8 6 4 2 0 Patients aged 36-82 ys., 16 G2 + 4 G3 Tumor stage: all patients=220/128) BZ DN KH DN Tis T1 T2 T3 T4 ASTRO criteria for PBI only suitable cautionary unsuitable 14 12 10 8 7 6 5 4 3 2 1 0 8 6 4 2 0 Tumor Stage IORT T1a T1b T1c T2 Mammosite volume 35 ml 40 ml 50 ml
Side effects After 5 days After 6 weeks Erythema 3/20 3/20 Epitheliolysis none none Pigmentation none 1/20 Edema 4/20 1/20 Seroma 3/20 1/20 Induration 5/20 8/20 No toxicity grade 3
Page 1 and 2: Gammamed and MammoSite for breast I
Page 3 and 4: ASTRO criteria for APBI as sole Sui
Page 5 and 6: ASTRO criteria for APBI as sole Uns
Page 7 and 8: PBI- the German situation Federal M
Page 9 and 10: Vaidya et al.: Lancet 2010 TARGIT:
Page 11 and 12: Treatment Modality for IORT spheric
Page 13 and 14: Dose distribution Dose (Gy) 12 10 8
Page 15 and 16: Treatment Modality for IORT spheric
Page 17 and 18: Patient Check-List Radiotherapy par
Page 19: Dose measurement 5-fold semiconduct
Page 23: Advantages and Disadvantages of mam

4.6 Schleicher, GammaMed and MammoSite - Varian

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?